BSE · WELCURE

Welcure Drugs & Pharmaceuticals ltd

Sector: Healthcare · ISIN: INE331C01025

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#3,851

of 5,004 stocks

🏆 New peak

▲ 321W

Peak #3,851 · 01 Oct 2026

A microcap name in Healthcare, Welcure Drugs & Pharmaceuticals ltd trades at an undemanding earnings multiple, is growing revenue rapidly, and has a subdued return on equity. Ownership as of Mar 2026.

Market Cap

25.95 Cr

P/E Ratio

5.25

P/B Ratio

0.27

ROE

-5.66%

ROCE

-1.85%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q4 2025-26	Q3 2025-26	Q2 2025-26	Q1 2025-26
Revenue	Rs 0	Rs 0	65.62 Cr	299.91 Cr
Net Profit	-49.86 Cr	1.07 Cr	8.50 Cr	23.30 Cr
EPS	0.40	0.13	0.76	2.07
Operating Profit	-49.86 Cr	1.43 Cr	11.36 Cr	31.14 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

0.00%

Public

100.00%

PUBLIC BREAKDOWN

Individuals

97.43%

As of 31 Mar 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
16 Oct 2025	Bonus	Bonus issue 1:10
16 Oct 2025	Split	Stock Split From Rs.10/- to Rs.1/-

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs